Home › Chronic Myelomonocytic Leukemia › Florida › Miami
Chronic Myelomonocytic Leukemia clinical trials in Miami, FL
4 studies for Chronic Myelomonocytic Leukemia are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
RecruitingPhase 2Healthy volunteers welcome
- University of Miami, Miami
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RecruitingPhase 2/3
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- University of Miami, Miami
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
RecruitingPhase 1/2
- University of Miami - Miller School of Medicine, Miami
Chronic Myelomonocytic Leukemia trials in other cities
- Houston, TX17 studies
- Seattle, WA11 studies
- Boston, MA8 studies
- Rochester, MN7 studies
- Mountain View, CA6 studies
- Baldwin Park, CA6 studies
- New York City, NY6 studies
- Durham, NC5 studies
- Tampa, FL4 studies
- Atlanta, GA4 studies
- Columbus, OH4 studies
- Birmingham, AL4 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer28 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.